Title : Metformin enhances the sensitivity of colorectal cancer cells to cisplatin through ROS-mediated PI3K/Akt signaling pathway.

Pub. Date : 2020 Jun 30

PMID : 32222530






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin enhances the sensitivity of colorectal cancer cells to cisplatin through ROS-mediated PI3K/Akt signaling pathway. Cisplatin AKT serine/threonine kinase 1 Homo sapiens
2 Moreover, NAC could recover the downregulation of p-PI3K and p-Akt treated with combination of metformin and cisplatin, which subsequently activated the PI3K/Akt signaling pathway. Cisplatin AKT serine/threonine kinase 1 Homo sapiens
3 Taken together, our results demonstrated that metformin enhanced the sensitivity of CRC cells to cisplatin through ROS-mediated PI3K/Akt signaling pathway. Cisplatin AKT serine/threonine kinase 1 Homo sapiens